234 related articles for article (PubMed ID: 38149258)
21. Inflammatory bowel disease and the risk of intracerebral hemorrhage: A Mendelian randomization study and meta-analysis.
Song Y; Zou X; Zeng Y; Zhang L; Mao X
Immun Inflamm Dis; 2023 Oct; 11(10):e1048. PubMed ID: 37904677
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
Chi G; Pei J; Li X
PLoS One; 2024; 19(6):e0305220. PubMed ID: 38848323
[TBL] [Abstract][Full Text] [Related]
23. Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study.
Dong X; Gong LL; Hong MZ; Pan JS
BMC Gastroenterol; 2024 Feb; 24(1):77. PubMed ID: 38373892
[TBL] [Abstract][Full Text] [Related]
24. Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease.
Chen J; Ruan X; Sun Y; Lu S; Hu S; Yuan S; Li X
EBioMedicine; 2024 Jan; 99():104934. PubMed ID: 38103512
[TBL] [Abstract][Full Text] [Related]
25. The causal effects of inflammatory bowel disease on primary biliary cholangitis: A bidirectional two-sample Mendelian randomization study.
Zhang H; Chen L; Fan Z; Lv G
Liver Int; 2023 Aug; 43(8):1741-1748. PubMed ID: 37283182
[TBL] [Abstract][Full Text] [Related]
26. Association between the use of lipid-lowering drugs and the risk of inflammatory bowel disease.
Liu X; Lv Z; Xie Z; Wang Q; Yao W; Yu J; Jing Q; Meng X; Ma B; Xue D; Hao C
Eur J Clin Invest; 2023 Dec; 53(12):e14067. PubMed ID: 37515404
[TBL] [Abstract][Full Text] [Related]
27. Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study.
Fang G; Kong F; Zhang H; Huang B; Zhang J; Zhang X
Front Immunol; 2023; 14():1168188. PubMed ID: 37228614
[TBL] [Abstract][Full Text] [Related]
28. Associations between sex hormones, receptors, binding proteins and inflammatory bowel disease: a Mendelian randomization study.
Zou F; Hu Y; Xu M; Wang S; Wu Z; Deng F
Front Endocrinol (Lausanne); 2024; 15():1272746. PubMed ID: 38660517
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the causal association between bronchiectasis and different types of inflammatory bowel disease: a two-sample Mendelian randomization study.
Zeng Q; Hu D; Li Y; Zhou Z; Wu J; Li X; Yu X
Front Immunol; 2024; 15():1365108. PubMed ID: 38638444
[TBL] [Abstract][Full Text] [Related]
30. Causal Association Between Inflammatory Bowel Disease and Psoriasis: A Two-Sample Bidirectional Mendelian Randomization Study.
Li Y; Guo J; Cao Z; Wu J
Front Immunol; 2022; 13():916645. PubMed ID: 35757704
[TBL] [Abstract][Full Text] [Related]
31. Risk relationship between inflammatory bowel disease and urolithiasis: A two-sample Mendelian randomization study.
Fu W; Zhu B; Chen J; Jin X
PLoS One; 2024; 19(4):e0301545. PubMed ID: 38593126
[TBL] [Abstract][Full Text] [Related]
32. Causal associations between inflammatory bowel disease and anxiety: A bidirectional Mendelian randomization study.
He Y; Chen CL; He J; Liu SD
World J Gastroenterol; 2023 Nov; 29(44):5872-5881. PubMed ID: 38111509
[TBL] [Abstract][Full Text] [Related]
33. The causal effect of inflammatory bowel disease on diffuse large B-cell lymphoma: two-sample Mendelian randomization study.
Lu C; Chen Q; Tao H; Xu L; Li J; Wang C; Yu L
Front Immunol; 2023; 14():1171446. PubMed ID: 37593734
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory bowel disease and risk of coronary heart disease : A Mendelian randomization study.
Qiu X; Hou C; Yang Z; Wang Q; Li L
Wien Klin Wochenschr; 2022 Nov; 134(21-22):779-787. PubMed ID: 36239805
[TBL] [Abstract][Full Text] [Related]
35. Exploring the causal relationship between inflammatory bowel disease and sarcopenia-related traits: a two-sample Mendelian randomization analysis.
Lin S; Zhang C; Chen C; Fan Y; Yang F
Aging (Albany NY); 2023 Dec; 16(1):799-819. PubMed ID: 38165807
[TBL] [Abstract][Full Text] [Related]
36. Mendelian randomization analysis reveals causal associations of inflammatory bowel disease with Spondylarthritis.
Wang M; He X
Gene; 2024 Apr; 902():148170. PubMed ID: 38237812
[TBL] [Abstract][Full Text] [Related]
37. Does inflammatory bowel disease promote kidney diseases: a mendelian randomization study with populations of European ancestry.
Lian X; Wang Y; Wang S; Peng X; Wang Y; Huang Y; Chen W
BMC Med Genomics; 2023 Sep; 16(1):225. PubMed ID: 37752523
[TBL] [Abstract][Full Text] [Related]
38. Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis.
Xiao X; Wu X; Yi L; You F; Li X; Xiao C
Front Endocrinol (Lausanne); 2024; 15():1275699. PubMed ID: 38313367
[TBL] [Abstract][Full Text] [Related]
39. Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study.
Lv X; Gao X; Liu J; Deng Y; Nie Q; Fan X; Ye Z; Liu P; Wen J
Front Immunol; 2022; 13():1042751. PubMed ID: 36582224
[TBL] [Abstract][Full Text] [Related]
40. Association between systemic lupus erythematosus and inflammatory bowel disease in European and East Asian populations: a two-sample Mendelian randomization study.
Xie W; Jiang H; Chen Y; Zhang H; Song Y; Yu Z; Gu H; Xu H; Han S; Li S; Liu N; Han S
Front Immunol; 2023; 14():1199896. PubMed ID: 38022503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
